Using syndromic measures of mortality to capture the dynamics of COVID-19 in Java, Indonesia, in the context of vaccination rollout
<p><strong>Background</strong> As in many countries, quantifying COVID-19 spread in Indonesia remains challenging due to testing limitations. In Java, non-pharmaceutical interventions (NPIs) were implemented throughout 2020. However, as a vaccination campaign launches, cases and de...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
BioMed Central
2021
|
| _version_ | 1797097568270811136 |
|---|---|
| author | Djaafara, BA Whittaker, C Watson, OJ Verity, R Brazeau, NF Widyastuti Oktavia, D Adrian, V Salama, N Bhatia, S Nouvellet, P Sherrard-Smith, E Churcher, TS Surendra, H Lina, RN Ekawati, LL Lestari, KD Andrianto, A Thwaites, G Baird, JK Ghani, AC Elyazar, IRF Walker, PGT |
| author_facet | Djaafara, BA Whittaker, C Watson, OJ Verity, R Brazeau, NF Widyastuti Oktavia, D Adrian, V Salama, N Bhatia, S Nouvellet, P Sherrard-Smith, E Churcher, TS Surendra, H Lina, RN Ekawati, LL Lestari, KD Andrianto, A Thwaites, G Baird, JK Ghani, AC Elyazar, IRF Walker, PGT |
| author_sort | Djaafara, BA |
| collection | OXFORD |
| description | <p><strong>Background</strong>
As in many countries, quantifying COVID-19 spread in Indonesia remains challenging due to testing limitations. In Java, non-pharmaceutical interventions (NPIs) were implemented throughout 2020. However, as a vaccination campaign launches, cases and deaths are rising across the island.</p>
<p><strong>Methods</strong>
We used modelling to explore the extent to which data on burials in Jakarta using strict COVID-19 protocols (C19P) provide additional insight into the transmissibility of the disease, epidemic trajectory, and the impact of NPIs. We assess how implementation of NPIs in early 2021 will shape the epidemic during the period of likely vaccine rollout.</p>
<p><strong>Results</strong>
C19P burial data in Jakarta suggest a death toll approximately 3.3 times higher than reported. Transmission estimates using these data suggest earlier, larger, and more sustained impact of NPIs. Measures to reduce sub-national spread, particularly during Ramadan, substantially mitigated spread to more vulnerable rural areas. Given current trajectory, daily cases and deaths are likely to increase in most regions as the vaccine is rolled out. Transmission may peak in early 2021 in Jakarta if current levels of control are maintained. However, relaxation of control measures is likely to lead to a subsequent resurgence in the absence of an effective vaccination campaign.</p>
<p><strong>Conclusions</strong>
Syndromic measures of mortality provide a more complete picture of COVID-19 severity upon which to base decision-making. The high potential impact of the vaccine in Java is attributable to reductions in transmission to date and dependent on these being maintained. Increases in control in the relatively short-term will likely yield large, synergistic increases in vaccine impact.</p> |
| first_indexed | 2024-03-07T04:57:25Z |
| format | Journal article |
| id | oxford-uuid:d712a206-3085-44da-a6cb-dc0ba01281df |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T04:57:25Z |
| publishDate | 2021 |
| publisher | BioMed Central |
| record_format | dspace |
| spelling | oxford-uuid:d712a206-3085-44da-a6cb-dc0ba01281df2022-03-27T08:38:28ZUsing syndromic measures of mortality to capture the dynamics of COVID-19 in Java, Indonesia, in the context of vaccination rolloutJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:d712a206-3085-44da-a6cb-dc0ba01281dfEnglishSymplectic ElementsBioMed Central2021Djaafara, BAWhittaker, CWatson, OJVerity, RBrazeau, NFWidyastutiOktavia, DAdrian, VSalama, NBhatia, SNouvellet, PSherrard-Smith, EChurcher, TSSurendra, HLina, RNEkawati, LLLestari, KDAndrianto, AThwaites, GBaird, JKGhani, ACElyazar, IRFWalker, PGT<p><strong>Background</strong> As in many countries, quantifying COVID-19 spread in Indonesia remains challenging due to testing limitations. In Java, non-pharmaceutical interventions (NPIs) were implemented throughout 2020. However, as a vaccination campaign launches, cases and deaths are rising across the island.</p> <p><strong>Methods</strong> We used modelling to explore the extent to which data on burials in Jakarta using strict COVID-19 protocols (C19P) provide additional insight into the transmissibility of the disease, epidemic trajectory, and the impact of NPIs. We assess how implementation of NPIs in early 2021 will shape the epidemic during the period of likely vaccine rollout.</p> <p><strong>Results</strong> C19P burial data in Jakarta suggest a death toll approximately 3.3 times higher than reported. Transmission estimates using these data suggest earlier, larger, and more sustained impact of NPIs. Measures to reduce sub-national spread, particularly during Ramadan, substantially mitigated spread to more vulnerable rural areas. Given current trajectory, daily cases and deaths are likely to increase in most regions as the vaccine is rolled out. Transmission may peak in early 2021 in Jakarta if current levels of control are maintained. However, relaxation of control measures is likely to lead to a subsequent resurgence in the absence of an effective vaccination campaign.</p> <p><strong>Conclusions</strong> Syndromic measures of mortality provide a more complete picture of COVID-19 severity upon which to base decision-making. The high potential impact of the vaccine in Java is attributable to reductions in transmission to date and dependent on these being maintained. Increases in control in the relatively short-term will likely yield large, synergistic increases in vaccine impact.</p> |
| spellingShingle | Djaafara, BA Whittaker, C Watson, OJ Verity, R Brazeau, NF Widyastuti Oktavia, D Adrian, V Salama, N Bhatia, S Nouvellet, P Sherrard-Smith, E Churcher, TS Surendra, H Lina, RN Ekawati, LL Lestari, KD Andrianto, A Thwaites, G Baird, JK Ghani, AC Elyazar, IRF Walker, PGT Using syndromic measures of mortality to capture the dynamics of COVID-19 in Java, Indonesia, in the context of vaccination rollout |
| title | Using syndromic measures of mortality to capture the dynamics of COVID-19 in Java, Indonesia, in the context of vaccination rollout |
| title_full | Using syndromic measures of mortality to capture the dynamics of COVID-19 in Java, Indonesia, in the context of vaccination rollout |
| title_fullStr | Using syndromic measures of mortality to capture the dynamics of COVID-19 in Java, Indonesia, in the context of vaccination rollout |
| title_full_unstemmed | Using syndromic measures of mortality to capture the dynamics of COVID-19 in Java, Indonesia, in the context of vaccination rollout |
| title_short | Using syndromic measures of mortality to capture the dynamics of COVID-19 in Java, Indonesia, in the context of vaccination rollout |
| title_sort | using syndromic measures of mortality to capture the dynamics of covid 19 in java indonesia in the context of vaccination rollout |
| work_keys_str_mv | AT djaafaraba usingsyndromicmeasuresofmortalitytocapturethedynamicsofcovid19injavaindonesiainthecontextofvaccinationrollout AT whittakerc usingsyndromicmeasuresofmortalitytocapturethedynamicsofcovid19injavaindonesiainthecontextofvaccinationrollout AT watsonoj usingsyndromicmeasuresofmortalitytocapturethedynamicsofcovid19injavaindonesiainthecontextofvaccinationrollout AT verityr usingsyndromicmeasuresofmortalitytocapturethedynamicsofcovid19injavaindonesiainthecontextofvaccinationrollout AT brazeaunf usingsyndromicmeasuresofmortalitytocapturethedynamicsofcovid19injavaindonesiainthecontextofvaccinationrollout AT widyastuti usingsyndromicmeasuresofmortalitytocapturethedynamicsofcovid19injavaindonesiainthecontextofvaccinationrollout AT oktaviad usingsyndromicmeasuresofmortalitytocapturethedynamicsofcovid19injavaindonesiainthecontextofvaccinationrollout AT adrianv usingsyndromicmeasuresofmortalitytocapturethedynamicsofcovid19injavaindonesiainthecontextofvaccinationrollout AT salaman usingsyndromicmeasuresofmortalitytocapturethedynamicsofcovid19injavaindonesiainthecontextofvaccinationrollout AT bhatias usingsyndromicmeasuresofmortalitytocapturethedynamicsofcovid19injavaindonesiainthecontextofvaccinationrollout AT nouvelletp usingsyndromicmeasuresofmortalitytocapturethedynamicsofcovid19injavaindonesiainthecontextofvaccinationrollout AT sherrardsmithe usingsyndromicmeasuresofmortalitytocapturethedynamicsofcovid19injavaindonesiainthecontextofvaccinationrollout AT churcherts usingsyndromicmeasuresofmortalitytocapturethedynamicsofcovid19injavaindonesiainthecontextofvaccinationrollout AT surendrah usingsyndromicmeasuresofmortalitytocapturethedynamicsofcovid19injavaindonesiainthecontextofvaccinationrollout AT linarn usingsyndromicmeasuresofmortalitytocapturethedynamicsofcovid19injavaindonesiainthecontextofvaccinationrollout AT ekawatill usingsyndromicmeasuresofmortalitytocapturethedynamicsofcovid19injavaindonesiainthecontextofvaccinationrollout AT lestarikd usingsyndromicmeasuresofmortalitytocapturethedynamicsofcovid19injavaindonesiainthecontextofvaccinationrollout AT andriantoa usingsyndromicmeasuresofmortalitytocapturethedynamicsofcovid19injavaindonesiainthecontextofvaccinationrollout AT thwaitesg usingsyndromicmeasuresofmortalitytocapturethedynamicsofcovid19injavaindonesiainthecontextofvaccinationrollout AT bairdjk usingsyndromicmeasuresofmortalitytocapturethedynamicsofcovid19injavaindonesiainthecontextofvaccinationrollout AT ghaniac usingsyndromicmeasuresofmortalitytocapturethedynamicsofcovid19injavaindonesiainthecontextofvaccinationrollout AT elyazarirf usingsyndromicmeasuresofmortalitytocapturethedynamicsofcovid19injavaindonesiainthecontextofvaccinationrollout AT walkerpgt usingsyndromicmeasuresofmortalitytocapturethedynamicsofcovid19injavaindonesiainthecontextofvaccinationrollout |